Cite

HARVARD Citation

    Tan, B. et al. (2018). Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer. Journal of clinical laboratory analysis. 32 (4), p. n/a. [Online]. 
  
Back to record